You are about to leave the Clinical Value website now.

Cancel

Cancer Type: Liver

HKASLD Consensus Recommendations: PIVKA-II for the surveillance and monitoring of HCC in Hong Kong

Posted on by Isabel Low
Prof-Grace-Wong

…

End-to-end liver disease management at Zhuhai People’s Hospital: Project Pearl

Posted on by Isabel Low
End to end liver disease management at Zhuhai Peoples Hospital Project Pearl featured image

…

Pioneering Innovations in HCC Detection for Enhance Patient Outcomes – Chang Gung Memorial Hospital

Posted on by Isabel Low
Pioneering Innovations in HCC Detection for Enhance Patient Outcomes Chang Gung Memorial Hospital featured image

…

Strategic Efficiencies: Evaluating Cost-Effectiveness of Biomarker-Based HCC Surveillance

Posted on by Isabel Low
Strategic Efficiencies Evaluating Cost Effectiveness of Biomarker Based HCC Surveillance featured image

…

A Bold Stride Forward for Liver Health: Thailand’s Nationwide HBV Screening and EZ Liver Clinic

Posted on by Isabel Low
Final-thumbnail

…

Cost-Utility of Novel Biomarker-Based Strategies for Hepatocellular Carcinoma (HCC) Surveillance in Thailand

Posted on by Isabel Low
Cost Utility of Novel Biomarker Based Strategies for Hepatocellular Carcinoma HCC Surveillance in Thailand featured image

…

The information contained in this website is intended for healthcare professionals only.
Click “OK” if you are a healthcare professional.

OK